Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to $2.5 ...

1 day ago · Eli Lilly said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of cancer treatments.

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics' Cancer Therapy For Up To $2.5 ...

2 weeks from now

1 day ago · Eli Lilly said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of cancer treatments.

reuters.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics Drug Program In $2.5 Billion ...

2 weeks from now

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 …

wsj.com

$2
OFF

Eli Lilly To Acquire Cancer Program From Scorpion Therapeutics

2 weeks from now

1 day ago · SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company …

statnews.com

$2
OFF

Eli Lilly To Buy Cancer Drug Developer Scorpion Therapeutics For

2 weeks from now

(Reuters) -Eli Lilly said on Monday it would buy cancer therapy developer Scorpion Therapeutics for up to $2.5 billion in cash. Lilly will acquire Scorpion's experimental oral therapy, STX-478 ...

msn.com

$2
OFF

Eli Lilly Scoops Up Scorpion Therapeutics' Early-Stage Cancer …

2 weeks from now

1 day ago · Eli Lilly will acquire Scorpion's PI3Kα inhibitor STX-478 for up to $2.5 billion, including a $1 billion upfront payment. Scorpion will spin out a new entity, retaining non-PI3Kα assets, …

benzinga.com

$2
OFF

Eli Lilly To Acquire Scorpion For Up To $2.5B - MSN

2 weeks from now

Eli Lilly (NYSE:LLY) has agreed to buy Scorpion Therapeutics' lead drug program for up to $2.5B in cash and spin out the remaining company as a new entity focused on precision medicine. …

msn.com

$2
OFF

Lilly To Pay As Much As $2.5 Billion For Scorpion’s Cancer Drug

2 weeks from now

1 day ago · Eli Lilly & Co. will pay as much as $2.5 billion in cash to acquire a cancer drug that Scorpion Therapeutics Inc. is testing in early and mid-stage trials.

bloomberg.com

$2
OFF

Eli Lilly In Advanced Talks To Buy US Cancer Biotech For Up To $2.5bn

2 weeks from now

4 days ago · Eli Lilly, the world’s largest drugmaker by market value, is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5bn, according to …

ft.com

$2
OFF

Eli Lilly To Acquire Scorpion Therapeutics’ Cancer Program For Up …

2 weeks from now

Pharmaceutical company Eli Lilly has entered into a definitive agreement to acquire Scorpion Therapeutics’ cancer therapy program for up to $2.5 billion as part of its efforts to strengthen …

forbesmiddleeast.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics Drug Program In $2.5 Billion ...

2 weeks from now

1 day ago · Eli Lilly has agreed to acquire Scorpion Therapeutics' breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and …

marketscreener.com

$2
OFF

Eli Lilly Targets Scorpion Therapeutics To Expand Reach In Oncology

2 weeks from now

22 hours ago · Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα inhibitor for upto $2.5bn in cash, with the latter splitting away to form a new entity with its remaining assets. …

yahoo.com

$2
OFF

Eli Lilly To Acquire Scorpion Therapeutics' Mutant PI3Kα Inhibitor …

2 weeks from now

23 hours ago · NEW YORK – Eli Lilly on Monday said it will acquire Scorpion Therapeutics' mutant-PI3Kα inhibitor STX-478 for up to $2.5 billion while Scorpion spins out a new entity to …

precisionmedicineonline.com

$2
OFF

Lilly In Advanced Talks To Buy Cancer Biotech Scorpion For Up To …

2 weeks from now

4 days ago · Eli Lilly is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks told Financial Times’ Oliver Barnes, Maria …

businessinsider.com

$2
OFF

Eli Lilly To Buy Scorpion Therapeutics Drug Program In $2.5

2 weeks from now

1 day ago · Eli Lilly agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash.

yahoo.com

$2
OFF

Lilly Acquires Scorpion’s Cancer Drug In $2.5 Billion Deal

2 weeks from now

1 day ago · INDIANAPOLIS and BOSTON - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with a market capitalization of $720 billion and a "GOOD" InvestingPro financial health …

investing.com

$2
OFF

Eli Lilly To Acquire Cancer-Focused Biotech Scorpion Therapeutics …

2 weeks from now

4 days ago · Eli Lilly, the world’s largest drugmaker by market value, is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5bn. Eli Lilly’s pursuit …

healthcarepress.net

$2
OFF

Lilly Acquires Scorpion's Cancer Drug In $2.5 Billion Deal

2 weeks from now

1 day ago · INDIANAPOLIS and BOSTON - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with a market capitalization of $720 billion and a "GOOD" InvestingPro financial health …

investing.com

$2
OFF

Lilly Acquires Scorpion's Cancer Drug In $2.5 Billion Deal

2 weeks from now

1 day ago · INDIANAPOLIS and BOSTON - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with a market capitalization of $720 billion and a "GOOD" InvestingPro financial health …

investing.com

FAQs about Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to $2.5 ... Coupon?

Will Lilly buy Scorpion Therapeutics?

(Reuters) -Eli Lilly said on Monday it would buy cancer therapy developer Scorpion Therapeutics for up to $2.5 billion in cash. Lilly will acquire Scorpion's experimental oral therapy, STX-478, which is currently being tested in early-stage trials for breast cancer and other advanced solid tumors. ...

Why did Eli Lilly buy Scorpion?

Eli Lilly’s pursuit of privately owned Scorpion is the latest example of its strategy of redistributing the huge windfall from its blockbuster diabetes and obesity drugs Mounjaro and Zepbound into diversifying its pipeline. ...

Who owns Scorpion Therapeutics?

"Eli Lilly targets Scorpion Therapeutics to expand reach in oncology" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. After selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a different entity, which will be owned by the biotech’s current shareholders. ...

How much will Lilly pay Scorpion shareholders?

Scorpion's lead drug asset, a mutant-selective PI3Kα inhibitor known as STX-478, is currently in Phase 1/2 testing for the treatment of breast cancer and other solid tumors. Under the deal, Lilly will pay Scorpion shareholders up to $2.5B in cash, including an upfront payment and potential milestone payments. ...

Will Eli Lilly buy PI3K inhibitor kisunla?

Eli Lilly's Alzheimer's drug Kisunla has secured regulatory approval in the UK · Pharmaceutical Technology · Michael Vi via Shutterstock. Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα inhibitor for upto $2.5bn in cash, with the latter splitting away to form a new entity with its remaining assets. ...

Does Eli Lilly have a market share in breast cancer treatment?

Eli Lilly already has market share in the breast cancer space with the approved drug Verzenio (abemaciclib), and is advancing investigational drugs like the oral selective estrogen receptor degrader (SERD) imlunestrant. ...